DEFA14A: Tarsus Pharmaceuticals Sets Date for 2025 Annual Stockholders Meeting
Proxy Statement
Tarsus Pharmaceuticals will hold its annual stockholders meeting on June 12, 2025, to elect directors, vote on executive compensation, and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
Summary
- Tarsus Pharmaceuticals, Inc. will hold its annual meeting of stockholders on June 12, 2025.
- The meeting will take place at 9:00 AM Pacific Daylight Time and will be held live via the internet.
- Stockholders of record as of April 14, 2025, are eligible to vote.
- The agenda includes the election of Class II directors to serve until the 2028 annual meeting, an advisory vote on executive compensation, and a vote on the frequency of future executive compensation votes.
- Stockholders will also vote to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- The Board of Directors recommends voting FOR proposals 1, 2, and 4.
- The Board recommends holding an advisory vote on executive compensation every 1 year.
Sentiment
Score: 5
Explanation: The document is a neutral announcement of an upcoming annual meeting with standard agenda items.
Positives
- The meeting provides stockholders with the opportunity to participate in key decisions regarding the company's governance and executive compensation.
- Stockholders have the option to access proxy materials online or request paper copies.
Future Outlook
The document outlines the agenda for the upcoming annual meeting, focusing on corporate governance and executive compensation matters.
Industry Context
This is a standard annual meeting announcement, typical for publicly traded companies to ensure shareholder participation in key decisions.
Stakeholder Impact
- Stockholders have the opportunity to influence the company's direction through voting.
- The outcome of the votes on executive compensation and the appointment of the auditor will impact the company's governance and financial oversight.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the annual meeting on June 12, 2025.
Key Dates
| Date | Description |
|---|---|
| April 14, 2025 | Stockholders of record date for the annual meeting. |
| June 2, 2025 | Deadline to request paper copies of proxy materials. |
| June 12, 2025 | Date of the Annual Meeting of Stockholders. |
| December 31, 2025 | Fiscal year end date for which Ernst & Young LLP is being ratified as the independent auditor. |
Keywords
Annual Meeting, Stockholders, Proxy Statement, Executive Compensation, Board of Directors, Ernst & Young, Tarsus Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.